Vivet Therapeutics
Accueil
- Business Model
- B2B
- Website
- vivet-therapeutics.com
- Total Funding
- $43.7M
- Last Round
- $43.7M Series AApr 2017
- Rounds
- 1
About
Vivet Therapeutics is a clinical-stage biotechnology company developing novel gene therapy treatments for rare, inherited metabolic diseases. It is building a diversified pipeline on recombinant adeno-associated virus (rAAV) technologies licensed from FIMA at CIMA, University of Navarra in Pamplona, Spain. Programs include VTX-PID to help patients with pre-existing AAV antibodies access gene therapy, VTX-806 for cerebrotendinous xanthomatosis, and VTX-801 for Wilson's disease. The company is backed by investors including Novartis Venture Fund, Roche Venture Fund, HealthCap, and Pfizer.
Summary
Vivet Therapeutics is a Biotech company. It has raised $43.7M in total across 1 round, most recently a $43.7M Series A round in Apr 2017.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Apr 2017
Similar Companies
Specialty pharmaceutical company focused on addressing therapeutic needs in the fields of psychia...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/vivet-therapeutics"><img src="https://indexed.vc/api/badge/company/vivet-therapeutics" alt="Vivet Therapeutics on Indexed.vc" width="260" height="76" /></a>